News und Analysen
Poxel Announces PXL770 Awarded FDA Fast Track Designation for X-linked Adrenoleukodystrophy
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Verimatrix Announces Participation in Three NAB Show Sessions, April 24-26 in Las Vegas
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the following NAB Show sessions taking place
NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities
Transgene to Present New Positive Preliminary Phase I Clinical Data at AACR 2022, Reinforcing the Potential of TG4050
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, will present additional positive
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.P
Website
Cybertrust implementiert IoT-Sicherheit von Verimatrix für Kunden in ganz Japan
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass die in Tokio ansässige Cybertrust Co.,
ESI Group beruft Florence Barré zur Stabschefin und zum Mitglied des Führungsteams
ESI Group (ISIN Code: FR0004110310, Symbol: ESI), ein weltweiter Softwarepartner der Industrie für Simulation und virtuelles Prototyping, beruft Florence Barré mit Wirkung vom 29. März 2022 zur
Cybertrust Deploys Verimatrix IoT Security for Customers Across Japan
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Tokyo-based Cybertrust Co., Ltd. began
ESI Group Appoints Florence Barré Chief of Staff and Member of the Leadership Team
Regulatory News:
ESI Group (ISIN Code: FR0004110310, Symbol: ESI), a global simulation and virtual prototyping software partner for the industry, appoints Florence Barré as Chief of Staff to
Transgene: Availability of Preparatory Documents for the Combined General Meeting of May 25, 2022
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies, announced that the documentation related to the Combined
GAUSSIN Announces the Start of Delivery of 36 APM 75T HE Electric Tractors, 24 POWERPACKS LMP® and 6 Charging Stations Ordered by CÔTE D'IVOIRE TERMINAL
GAUSSIN (EURONEXT GROWTH ALGAU - FR0013495298), a pioneer in the clean and intelligent transport of goods and people, announces it has started delivering on the order of 36 APM 75T HE electric
Die Bedrohungsabwehr von Verimatrix ermöglicht Capri Healthcare die sichere Digitalisierung der Arzt-Patienten-Betreuung
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass Capri Healthcare sich für App Shield von Verimatrix
Verimatrix Threat Defense Empowers Capri Healthcare to Safely Digitize Doctor-Patient Care
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Capri Healthcare chose Verimatrix App
NANOBIOTIX Provides Business Update and Reports Full Year 2021 Financial Results
Regulatory News:
NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities
Indischer MSO GTPL Hathway wählt Verimatrix zum Schutz seiner umfangreichen Einführung von Android TV
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, teilte heute mit, dass GTPL Hathway Limited („GTPL“)
India's GTPL Hathway Selects Verimatrix To Secure Sweeping Android TV Rollout
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that GTPL Hathway Limited
Poxel Reports Financial Results for Full Year 2021 and Provides Corporate Update
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including
Von Verimatrix in Auftrag gegebene Umfrage zeigt das Ausmaß an Betrügereien, Hacking und Piraterie im E-Sport
Verimatrix, (Euronext Paris: VMX), der führende Anbieter von benutzerorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute die Veröffentlichung einer eigens in Auftrag
Verimatrix-Commissioned Survey Highlights Scale of E-Sports Cheating, Hacking and Piracy
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced the release of its commissioned survey conducted by Omdia and the
NANOBIOTIX to Announce Full Year 2021 Financial Results on March 30, 2022
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’) (Paris:NANO) (NASDAQ:NBTX), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment
GAUSSIN Presents World's First Hydrogen-Powered Fuel Cell Automated Guided Vehicles (AGV H2) for Ports Application
GAUSSIN (EURONEXT GROWTH ALGAU - FR0013495298), a pioneer in the clean and intelligent transport of goods and people, announces the launch of the world's first hydrogen-powered fuel cell Automated
Transgene Confirms the Potential of Its Two Innovative Platforms and Expects Significant Clinical Results in 2022
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial
Poxel to Report Financial Results for Full Year 2021 and Host Webcast Call on March 22, 2022
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Transgene to Present New Positive Preliminary Phase I Data on TG4050 (myvac® platform), its Individualized Therapeutic Cancer Vaccine, at AACR 2022
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer will be presenting a poster with
Transgene and BioInvent Announce Poster Presentation on BT-001, a Novel Antibody-encoding Oncolytic Virus, at AACR 2022
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq